Eli Lilly has requested Europe's medicines regulator to re-examine its opinion on the company's Alzheimer's drug, the agency ...

Eli Lilly has requested Europe's drug regulator to re-examine its opinion on the company's Alzheimer's drug, the agency said ...

Johnson, a family friend, visited the woman’s Port Hueneme home, where she lived with her daughter in February 2020, ...

Researchers are looking for 200 healthy adults between 65 and 75 who have a close family member with dementia but who do not ...

Zahydie Burgos Ribot and her husband Francisco are working on completing their travel bucket list and spending quality time ...

An extended family in that South American country has a devastating genetic variant that triggers early-onset dementia. "They ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with ...

When parents imagine their child's future, they picture graduations, careers, and perhaps families of their own. For Bryan ...

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...